Patent · US Active

Combination of sPLA2 activity and oxPL/apoB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event

US8361732B2 · kind B2 · utility

1Cited by

3References

4Claims

0Family size

Assignees

INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) · FR
The Regents of the University of California · US
UNIVERSITÉ PARIS DIDEROT—PARIS 7 · FR

Inventors

Ziad Mallat · Paris, FR
Alain Tedgui · Paris, FR
Sotirios Tsimikas · San Diego, US
Joseph L. Witztum · San Diego, US

Key dates

Filing date	Mar 9, 2012
Grant date	Jan 29, 2013
Priority date	—
Expiry date	Mar 9, 2032

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/50
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The use of a combination of sPLA2 activity and OxPL/apoB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event or for the monitoring of a cardiovascular disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.